Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 1, 2010, Pages

  Omodeo Sale F ^a   Cortelezzi, L ^a   Vommaro, Z ^a   Scaccabarozzi, D ^a   Dondorp, A M ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Arginase; Ferriprotoporphyrin IX; Malaria

Indexed keywords

AMINO ACID TRANSPORTER; ARGINASE 1; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME; NITRIC OXIDE; ORNITHINE; PROTOPORPHYRIN; UREA;

ARTICLE; BIOAVAILABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; HYDROLYSIS; METABOLIC REGULATION; PLASMA; PRIORITY JOURNAL;

AMINO ACID TRANSPORT SYSTEM Y+; AMINO ACID TRANSPORT SYSTEM Y+L; ARGINASE; ARGININE; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CITRULLINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ERYTHROCYTES; HEMIN; HUMANS; HYDROLYSIS; KINETICS; MALARIA, FALCIPARUM; MICROVESSELS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ORNITHINE; UREA;

PLASMODIUM FALCIPARUM;

EID: 77953786118     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00405.2009     Document Type: Article

References (42)

1. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184: 557-567, 1996.
2. Bottini E. Association between cytosolic low molecular weight phosphotyrosine-phosphatase and malaria - a possible mechanism. Am J Phys Anthropol 108: 241-244, 1999.
3. Boyd CA, Deves R, Laynes R, Kudo Y, Sebastio G. Cationic amino acid transport through system y+L in erythrocytes of patients with lysinuric protein intolerance. Pflügers Arch 439: 513-516, 2000. (Pubitemid 30140141)
4. Brown SB, Shillcock M, Jones P. Equilibrium and kinetic studies of the aggregation of porphyrins in aqueous solution. Biochem J 153: 279-285, 1976.
5. Casals-Pascual C, Kai O, Cheung JO, Williams S, Lowe B, Nyanoti M, Williams TN, Maitland K, Molyneux M, Newton CR, Peshu N, Watt SM, Roberts DJ. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 108: 2569-2577, 2006.
6. Chou AC, Fitch CD. Mechanism of hemolysis induced by ferriprotoporphyrin IX. J Clin Invest 68: 672-677, 1981.
7. Coghi P, Basilico N, Taramelli D, Chan WC, Haynes RK, Monti D. Interaction of artemisinins with oxyhemoglobin Hb-FeII, Hb-FeII, carboxyHb-FeII, heme-FeII, and carboxyheme FeII: significance for mode of action and implications for therapy of cerebral malaria. Chem Med Chem 4: 2045-2053, 2009.
8. Corraliza IM, Campo ML, Soler G, Modolell M. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174: 231-235, 1994.
9. Dondorp AM, Pongponratn E, White NJ. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop 89: 309-317, 2004.
10. Iuvone T, D'Acquisto F, Carnuccio R, Di Rosa M. Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci 59: PL207-PL211, 1996.
11. Iyamu EW, Cecil R, Parkin L, Woods G, Ohene-Frempong K, Asakura T. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy. Br J Haematol 131: 389-394, 2005.
12. Iyamu EW, Perdew H, Woods GM. Cysteine-iron promotes arginase activity by driving the Fenton reaction. Biochem Biophys Res Commun 376: 116-120, 2008.
13. Jiang M, Ding Y, Su Y, Hu X, Li J, Zhang Z. Arginase-flotillin interaction brings arginase to red blood cell membrane. FEBS Lett 580: 6561-6564, 2006.
14. Kleinbongard P, Keymel S, Kelm M. New functional aspects of the L-arginine-nitric oxide metabolism within the circulating blood. Thromb Haemost 98: 970-974, 2007.
15. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozuyaman B, Schnurch HG, Godecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rosen P, Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood 107: 2943-2951, 2006.
16. Korman SH, Gutman A, Stemmer E, Kay BS, Ben-Neriah Z, Zeigler M. Prenatal diagnosis for arginase deficiency by second-trimester fetal erythrocyte arginase assay and first-trimester ARG1 mutation analysis. Prenat Diagn 24: 857-860, 2004.
17. Kurz S, Harrison DG. Insulin and the arginine paradox. J Clin Invest 99: 369-370, 1997.
18. Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC, Mwaikambo ED, Granger DL. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361: 676-678, 2003.
19. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitricoxide synthase may explain the "arginine paradox." J Biol Chem 272: 31213-31216, 1997.
20. Gmonomethyl-L-arginine in human erythrocytes in chronic renal failure. Clin Sci (Lond) 93: 57-64, 1997.
21. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294: 81-90, 2005.
22. Mukai M, Savard PY, Ouellet H, Guertin M, Yeh SR. Unique ligand-protein interactions in a new truncated hemoglobin from Mycobacterium tuberculosis. Biochemistry 41: 3897-3905, 2002.
23. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 163: 3771-3777, 1999. (Pubitemid 29450901)
24. Nuchsongsin F, Chotivanich K, Charunwatthana P, Omodeo-Sale F, Taramelli D, Day NP, White NJ, Dondorp AM. Effects of malaria heme products on red blood cell deformability. Am J Trop Med Hyg 77: 617-622, 2007.
25. Omodeo-Sale F, Cortelezzi L, Riva E, Vanzulli E, Taramelli D. Modulation of glyceraldehyde 3 phosphate dehydrogenase activity and tyr-phosphorylation of Band 3 in human erythrocytes treated with ferriprotoporphyrin IX. Biochem Pharmacol 74: 1383-1389, 2007.
26. Omodeo Salé F, Motti A, Dondorp A, White NJ, Taramelli D. Destabilization and subsequent lysis of human erythrocytes induced by Plasmodium falciparum heme products. Eur J Haematol 74: 324-332, 2005.
27. Ozuyaman B, Grau M, Kelm M, Merx MW, Kleinbongard P. RBC NOS: regulatory mechanisms and therapeutic aspects. Trends Mol Med 14: 314-322, 2008.
28. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13: 703-710, 2007. (Pubitemid 46889755)
29. Pantaleo A, Ferru E, Giribaldi G, Mannu F, Carta F, Matte A, de Franceschi L, Turrini F. Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochem J 418: 359-367, 2009.
30. Pawloski JR, Swaminathan RV, Stamler JS. Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation. Circulation 97: 263-267, 1998. (Pubitemid 28067312)
31. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92: 639-646, 1987.
32. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057-1058, 1987. (Pubitemid 17154788)
33. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293: 1653-1662, 2005.
34. Schnorr O, Brossette T, Momma TY, Kleinbongard P, Keen CL, Schroeter H, Sies H. Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 476: 211-215, 2008.
35. Serirom S, Raharjo WH, Chotivanich K, Loareesuwan S, Kubes P, Ho M. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol 162: 1651-1660, 2003. (Pubitemid 36512848)
36. Shima Y, Maeda T, Aizawa S, Tsuboi I, Kobayashi D, Kato R, Tamai I. L-Arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes. Blood 107: 1352-1356, 2006.
37. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001.
38. Winterbourn CC. Oxidative reactions of hemoglobin. Methods Enzymol 186: 265-272, 1990.
39. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1-17, 1998. (Pubitemid 28532555)
40. Wyatt AW, Steinert JR, Mann GE. Modulation of the L-arginine/nitric oxide signalling pathway in vascular endothelial cells. Biochem Soc Symp 71: 143-156, 2004. (Pubitemid 41185483)
41. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93: 6770-6774, 1996.
42. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 204: 2693-2704, 2007.